Northwestern Mutual Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4	Buy	+3	New	+$5	﹤0.01%	4095

Other funds holding VVOS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northwestern Mutual Wealth Management's VVOS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Vivos Therapeutics (VVOS) in Q1 2026: 3 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #4095 among its holdings.

24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

Northwestern Mutual Wealth Management held 3 shares of Vivos Therapeutics worth $4 as of Q1 2026.
Vivos Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
Vivos Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4095 holding.
24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.